You've thought about the money. Most ophthalmologists within a decade of retirement have run the numbers at least once. What the laser is worth, what the tax hit looks like on the equipment, whether selling makes more sense than closing. The financial side of walking away has a rough shape even if the details aren't final. The question that almost never makes it into those conversations is the one your patients would ask if anyone gave them the chance. What happens to me when you're gone?
The Vanishing Practice
Picture a refractive surgeon who built a solo cash pay practice over 25 years. LASIK, PRK, ICL, refractive lens exchange. About 3,800 active patients, some still coming in for annual follow ups from procedures he did a decade ago. Two experienced techs who can run every diagnostic in the office without being told. A patient coordinator who's been there since the beginning and knows every consultation flow by heart. A reputation that took a quarter century to build, mostly by word of mouth, because that's how refractive practices grow.
He retires on a Friday in March and by Monday the phones are off. Patients who call get a recording. Two weeks later a form letter goes out explaining that records can be requested in writing. His post surgical patients, roughly 200 in various stages of follow up from LASIK, ICL, and lens exchange, have no provider for ongoing monitoring. His pipeline of consultations, people who were referred by former patients and were weeks away from booking their procedure, evaporates overnight. His patient coordinator is filing for unemployment.
The practice wasn't failing. He just couldn't find a buyer in 18 months of looking, couldn't afford to keep the doors open while he searched, and nobody ever showed him a third option between selling and shutting down. 3,800 patients got a letter and 25 years of clinical relationships ended with a recording.
This isn't rare. It's the default outcome for solo refractive surgeons who retire without a succession plan, and in a cash pay specialty where the entire practice runs on trust, the damage is total. There's no insurance network to redirect patients and no hospital system to absorb the panel. When a solo refractive practice closes, the patients scatter, and most of them delay care they shouldn't be delaying.
Solo refractive surgeons don't have a built in succession path. There's no second surgeon waiting and no institutional pipeline feeding new talent into the practice. Unlike a hospital system where the phones stay on regardless of who leaves, the solo practitioner is the practice, and when they walk out the lights go off. The options are all imperfect.
Finding another surgeon who wants your specific practice, in your geography, who can perform your full procedure mix, at a price that reflects what you built, on a timeline that works for your retirement is harder than it sounds. Most never find one, and the ones who do usually spend 12 to 24 months searching while the practice coasts because the owner has mentally checked out. Consultation volume drops, referrals slow, and the practice a buyer shook hands on in January is a different practice by September.
Selling to private equity comes with its own cost. Staff gets cut, the brand gets absorbed into a platform name your patients don't recognize, and the surgeon who shows up through a PE roll up has no relationship with the patient who trusted your hands with their vision for the last 15 years. In a cash pay refractive practice where the entire business runs on personal trust and word of mouth, stripping the identity is the same as stripping the revenue.
And then there's closing the doors, which is what happens when the first two options felt too complicated, too slow, or too uncertain. Every time this happens, thousands of patients lose their provider overnight.
The Successor Physician Problem
When succession planning works, it looks nothing like a closing. The successor starts seeing patients while the retiring surgeon is still in the building. Consultations for new LASIK or ICL patients happen with the incoming doctor while the founder is down the hall, and post surgical follow ups transfer with context. The kind of notes that say "she's anxious about any vision change, always give her extra time" and "he did well with LASIK in the right eye, left eye is scheduled for next month, he prefers direct explanations over pamphlets."
Staff stay because the practice still feels like the same place. The phone number stays the same and the consultation flow that the patient coordinator built over a decade keeps running. From the patient's perspective, the practice kept going with a new surgeon in the room, and that's an entirely different experience than getting a letter in the mail.
That kind of transition requires identifying the successor surgeon early enough to build a runway, operational support so the retiring doctor isn't managing a handoff and a full surgical schedule at the same time, and a management framework that treats patient continuity as a design principle rather than an afterthought. That's what the MSO model is designed to do.
Source the successor physician early, build the operational bridge between the retiring surgeon and the incoming one, and keep the infrastructure intact through the change in clinical leadership. In a cash pay specialty where trust is the product, continuity isn't optional. It's the business model.
The structural answer to this problem already exists. A physician owned PC with an MSO providing operational support through a management services agreement where the physician owns the clinical entity, the management company runs operations, and the MSA defines what each side does, pays, and happens if either side wants to walk away.
The difference from a PE deal comes down to four things. Ownership stays with the physician, meaning their name is on the clinical entity, their license governs clinical decisions, and their vote controls what happens inside the practice. The non-compete is geographic and fixed, covering the actual practice location, a defined radius, and a time period, and it doesn't expand when the management company acquires a practice in another zip code.
The exit is defined before the relationship starts. Both sides agree to the termination provisions upfront, with no rolling extensions and no breakup penalties designed to make leaving more expensive than staying. The consent process stays with the physician too, for example how long a consultation takes, how you explain the risks, how you talk to a patient sitting in your chair for the first time. In an MSO structure, those decisions never leave the exam room.
